Roivant Sciences raised €938M in a Growth/Late round in Aug 2017. The company is based in Basel, Switzerland. Investors in the round: SoftBank. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
